°í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : ¼ºñ½ºº°, ÈÇÕ¹°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2030³â)
High Level Disinfection Services Market Size, Share & Trends Analysis Report By Services (Inhouse, Outsource), By Compound (Formaldehyde, Glutaraldehyde, Peracetic Acid), By End-use, By Region, And Segment Forecasts, 2023 - 2030
»óǰÄÚµå
:
1376001
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2023³â 10¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 90 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
°í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå ¼ºÀå°ú µ¿Çâ:
Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é, ¼¼°è °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå ±Ô¸ð´Â 2023³âºÎÅÍ 2030³â±îÁö 7.3%ÀÇ CAGRÀ» ±â·ÏÇϸç 2030³â±îÁö 421¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º´¿ø ³» °¨¿° ¹× ¼ö¼ú ºÎÀ§ °¨¿°ÀÇ À¯º´·ü Áõ°¡, ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡¿Í ÇÔ²² ¼ö¼ú °Ç¼ö Áõ°¡, COVID-19ÀÇ ¿µÇâÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
À§»ý ¹× ¿¹¹æ Á¶Ä¡ ºÎÁ·À¸·Î ÀÎÇÑ HAI À¯º´·ü Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. 2017³â CDC°¡ ¹ßÇ¥ÇÑ º¸°í¼¿¡ µû¸£¸é, º´¿ø ³» °¨¿°À¸·Î ÀÎÇØ ¸Å³â 99,000¸í ÀÌ»óÀÌ »ç¸ÁÇϰí ÀÖÀ¸¸ç, û°áÇÏÁö ¾ÊÀº ÀÇ·á±â±â´Â º´¿ø ³» °¨¿°ÀÇ ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù. ¶ÇÇÑ antimicrobe.org¿¡ µû¸£¸é HAP´Â ÀÇ·á ÁßȯÀÚ½Ç(ICU)¿¡¼ ¹ß»ýÇÏ´Â Àüü º´¿ø ³» °¨¿°ÀÇ ¾à 27.00%¸¦ Â÷ÁöÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°µéÀº º´¿øÀÇ ´Ù¾çÇÑ ½Ã¼³ÀÇ ¼Òµ¶ ¹× ¼¼Ã´¿¡ ÇÊ¿äÇϱ⠶§¹®¿¡ ÀÌ·¯ÇÑ »ç·Ê´Â °í³óµµ ¼Òµ¶Á¦ ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ ±ÞÁõ½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ Àü ¼¼°èÀûÀ¸·Î COVID-19°¡ °©Àڱ⠹߻ýÇÑ °Íµµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀ̸ç, WorldometerÀÇ ÃßÁ¤¿¡ µû¸£¸é 2021³â 4¿ù 26ÀÏ ÇöÀç Àü ¼¼°è °¨¿°ÀÚ ¼ö´Â 147,884,279¸íÀ¸·Î Áý°èµÆ½À´Ï´Ù. Äڷγª ¹ÙÀÌ·¯½º °¨¿°ÀÚ°¡ Áõ°¡Çϸé ÁßÁõ Ä¡·á ¿ëǰ¿¡ ´ëÇÑ Çʿ伺ÀÌ ³ô¾ÆÁ® °í³óµµ ¼Òµ¶Á¦ ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ, ½ÃÀå¿¡¼ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷µéÀº COVID-19¿¡ È¿°úÀûÀÎ HLD¸¦ °³¹ßÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¶û¼¼½º´Â Reliance On VirkonÀ», Solvay´Â Äڷγª ¹ÙÀÌ·¯½º¿¡ È¿°úÀûÀÎ PROXITANEÀ» °³¹ßÇß½À´Ï´Ù. µû¶ó¼ ÀÌ·¯ÇÑ »ç·Ê´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇÒ °ÍÀÓÀ» º¸¿©ÁÝ´Ï´Ù.
°í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- 2022³â ¾Æ¿ô¼Ò½Ì ºÎ¹®ÀÌ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ºñ¿ë Àý°¨, ¸ÂÃãÇü ¼Òµ¶ ¼ºñ½º, ÷´Ü ±â¼ú »ç¿ë µî ¾Æ¿ô¼Ò½Ì°ú °ü·ÃµÈ ¸î °¡Áö ÀåÁ¡Àº ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.
- ±Û·çŸ¸£¾Ëµ¥È÷µå ºÎ¹®Àº 2022³â¿¡ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ¼ö¼ú °Ç¼ö Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®Àº 2022³â °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀº º´¿ø ³» °¨¿°ÀÇ Áõ°¡¿Í Äڷγª ¹ÙÀÌ·¯½º °¨¿°ÀÚ Áõ°¡°¡ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇß½À´Ï´Ù.
- ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼´Â ¸¸¼ºÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀÌ °¡Àå ºü¸¥ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå º¯¼ö, µ¿Çâ ¹× ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- »óºÎ ½ÃÀå Àü¸Á
- °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
- º¸±Þ°ú ¼ºÀå Àü¸Á ¸ÅÇÎ
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå ºÐ¼® Åø
- ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå : ¼ºñ½º ÃßÁ¤¡¤µ¿Ç⠺м®
- °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå, ¼ºñ½º ÁÖ¿ä Æ÷ÀÎÆ®º°
- °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå : ¼ºñ½º µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
- »ç³» ¼ºñ½º
- À§Å¹ ¼ºñ½º
Á¦5Àå °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå : ÄÄÆÄ¿îµå ÃßÁ¤¡¤µ¿Ç⠺м®
- °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå, ÄÄÆÄ¿îµåÀÇ Áß¿äÇÑ Æ÷ÀÎÆ®º°
- °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå : ÄÄÆÄ¿îµå µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
- Æ÷¸§¾Ëµ¥È÷µå
- ±Û·çŸ¸£¾Ëµ¥È÷µå
- ¿À¸£ÅäÇÁÅ»»ê ¿¡½ºÅ׸£
- °ú»êȼö¼Ò
- °úÃÊ»ê
- ±âŸ
Á¦6Àå °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå, ÃÖÁ¾ ¿ëµµÀÇ Áß¿äÇÑ Æ÷ÀÎÆ®
- °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå : ÃÖÁ¾ ¿ëµµ µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
- º´¿ø°ú Ŭ¸®´Ð
- Áø´Ü ½ÇÇè½Ç
- Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
- Çмú¿¬±¸±â°ü
- ±âŸ
Á¦7Àå °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
- Áö¿ªº° Àü¸Á
- Áö¿ªº° °í·¹º§ ¼Òµ¶ ¼ºñ½º ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
- ºÏ¹Ì
- ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2018-2030³â
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ÀϺ»
- Áß±¹
- Àεµ
- È£ÁÖ
- ű¹
- Çѱ¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- Äí¿þÀÌÆ®
Á¦8Àå °æÀï »óȲ
- ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ°ú ¿µÇ⠺м®
- ȸ»ç/°æÀï ºÐ·ù
- Ecolab
- GE Healthcare
- Altapure
- Olympus Corporation
- Getinge
- Fortive
- Lifemed Technologies Pvt Ltd.
- Steelco S.p.A
- STERIS
- Microchem Laboratory
- Metrex Research, LLC
- EcoFMR
- Jani-King International, Inc.
- Rentokil Initial plc
ksm
¿µ¹® ¸ñÂ÷
High Level Disinfection Services Market Growth & Trends:
The global high level disinfection services market size is expected to reach USD 42.12 billion by 2030, registering a CAGR of 7.3% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The increasing prevalence of hospital-acquired infection and surgical site infections, the increasing number of surgeries coupled with the rise in the incidence of chronic disorders, and the impact of COVID-19 are the key driving factors for the market.
An increase in the prevalence of HAIs due to a lack of sanitation and preventive measures is a major factor expected to propel market growth over the forecast period. Unclean medical devices are a key source of hospital-acquired infections. According to the report published by CDC in 2017, hospital-acquired infections result in more than 99,000 deaths every year. Also, according to antimicrobe.org, HAP accounts for around 27.00% of all nosocomial infections acquired in medical intensive care units (ICU). Since these products are needed for disinfection and cleaning of various hospital equipment, therefore, these instances are expected to surge the demand for high level disinfectant services.
Furthermore, the sudden outbreak of COVID-19 across the globe is one of the major factors propelling the market growth. According to the Worldometer estimates, as of 26th April 2021, there are total 147,884,279 cases globally. If more people become infected with the coronavirus, there will be a significant need for critical care supplies that will boost the demand for high-level disinfectant services. Furthermore, major players operating in the market are developing HLDs that are effective against COVID-19. For instance, LANXESS developed Rely+On Virkon and Solvay's PROXITANE, which is effective against the coronavirus. Hence, such instances indicate considerable market growth over the forecast period.
High Level Disinfection Services Market Report Highlights:
- The outsource segment held the largest revenue share in 2022. Several benefits associated with outsourcing such as cost-saving, customized disinfection services and usage of advanced technology is the major factor propelling segment growth
- The glutaraldehyde segment held the largest revenue share in 2022 and is expected to witness the fastest growth over the forecast period due to the increasing number of surgeries
- The hospitals and clinics segment held the largest revenue share in 2022. The segment growth is majorly driven by the increasing number of hospital-acquired infections and the rising number of people suffering from coronavirus
- In Asia Pacific, the market is expected to witness the fastest growth rate over the forecast period owing to the rising prevalence of chronic disorders
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Service
- 1.1.2. Compound
- 1.1.3. End use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Service outlook
- 2.2.2. Compound outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. High Level Disinfection Services Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. High Level Disinfection Services Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's Five Forces
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. High Level Disinfection Services Market: Service Estimates & Trend Analysis
- 4.1. High Level Disinfection Services Market, By Service Key Takeaways
- 4.2. High Level Disinfection Services Market: Service Movement & Market Share Analysis, 2022 & 2030
- 4.3. Inhouse Services
- 4.3.1. Inhouse services market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Outsourced Service
- 4.4.1. Outsourced service market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. High Level Disinfection Services Market: Compound Estimates & Trend Analysis
- 5.1. High Level Disinfection Services Market, By Compound Key Takeaways
- 5.2. High Level Disinfection Services Market: Compound Movement & Market Share Analysis, 2022 & 2030
- 5.3. Formaldehyde
- 5.3.1. Formaldehyde market estimates and forecasts, 2018 - 2030
- 5.4. Glutaraldehyde
- 5.4.1. Glutaraldehyde market estimates and forecasts, 2018 - 2030
- 5.5. Ortho-phthalalehyde
- 5.5.1. Ortho-phthalaldehyde estimates and forecasts, 2018 - 2030
- 5.6. Hydrogen Peroxide
- 5.6.1. Hydrogen peroxide market estimates and forecasts, 2018 - 2030
- 5.7. Peracetic Acid
- 5.7.1. Peracetic acid market estimates and forecasts, 2018 - 2030
- 5.8. Others
- 5.8.1 Others market estimates and forecasts, 2018 - 2030
Chapter 6. High Level Disinfection Services Market: End-use Estimates & Trend Analysis
- 6.1. High Level Disinfection Services Market, By End-use Key Takeaways
- 6.2. High Level Disinfection Services Market: End-use Movement & Market Share Analysis, 2022 & 2030
- 6.3. Hospitals & Clinics
- 6.3.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4. Diagnostic Laboratories
- 6.4.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Pharmaceutical & Biotechnology Companies
- 6.5.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Academic and Research Institutes
- 6.6.1. Academic and research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7. Others
- 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. High Level Disinfection Services Market: Regional Estimates & Trend Analysis
- 7.1. Regional Outlook
- 7.2. High Level Disinfection Services Market by Region: Key Takeaways
- 7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
- 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
- 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
- 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
- 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
- 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Denmark
- 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Norway
- 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
- 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
- 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
- 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
- 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
- 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Mexico
- 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7. MEA
- 7.7.1. South Africa
- 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
- 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.2.1. Ecolab
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. GE Healthcare
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Altapure
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Olympus Corporation
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Getinge
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Fortive
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Lifemed Technologies Pvt Ltd.
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. Steelco S.p.A
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. STERIS
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Microchem Laboratory
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives
- 8.2.11. Metrex Research, LLC
- 8.2.11.1. Company overview
- 8.2.11.2. Financial performance
- 8.2.11.3. Product benchmarking
- 8.2.11.4. Strategic initiatives
- 8.2.12. EcoFMR
- 8.2.12.1. Company overview
- 8.2.12.2. Financial performance
- 8.2.12.3. Product benchmarking
- 8.2.12.4. Strategic initiatives
- 8.2.13. Jani-King International, Inc.
- 8.2.13.1. Company overview
- 8.2.13.2. Financial performance
- 8.2.13.3. Product benchmarking
- 8.2.13.4. Strategic initiatives
- 8.2.14. Rentokil Initial plc
- 8.2.14.1. Company overview
- 8.2.14.2. Financial performance
- 8.2.14.3. Product benchmarking
- 8.2.14.4. Strategic initiatives
°ü·ÃÀÚ·á